TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 117 filers reported holding TG THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,542,000 | +452.6% | 229,001 | +179.6% | 0.12% | +443.5% |
| Q3 2019 | $460,000 | -64.1% | 81,901 | -44.7% | 0.02% | -68.5% |
| Q2 2019 | $1,282,000 | -36.0% | 148,201 | -40.5% | 0.07% | -39.2% |
| Q1 2019 | $2,004,000 | +256.0% | 249,201 | +81.6% | 0.12% | +233.3% |
| Q4 2018 | $563,000 | +275.3% | 137,201 | +411.6% | 0.04% | +414.3% |
| Q3 2018 | $150,000 | -85.5% | 26,819 | -65.9% | 0.01% | -83.3% |
| Q2 2018 | $1,034,000 | +77.7% | 78,652 | +35.6% | 0.04% | +35.5% |
| Q2 2017 | $582,000 | +131.0% | 58,000 | +7.0% | 0.03% | +106.7% |
| Q4 2016 | $252,000 | -53.1% | 54,200 | -38.9% | 0.02% | -44.4% |
| Q2 2016 | $537,000 | +231.5% | 88,654 | +552.3% | 0.03% | +237.5% |
| Q4 2015 | $162,000 | +6.6% | 13,591 | -9.9% | 0.01% | +33.3% |
| Q3 2015 | $152,000 | -56.1% | 15,091 | -27.7% | 0.01% | -50.0% |
| Q2 2015 | $346,000 | -62.5% | 20,862 | -64.2% | 0.01% | -64.7% |
| Q4 2014 | $922,000 | +1198.6% | 58,245 | +308.2% | 0.03% | +750.0% |
| Q3 2013 | $71,000 | – | 14,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |